SCHEMBL7248570

SCHEMBL7248570

CC(C)C[C@@H](C(=O)NCC(=O)CNS(=O)(=O)c1ccc(Oc2ccccc2)cc1)N(CC(=O)O)C(=O)c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSK P43235 3/20 0.61
▸ CTSS P25774 1/20 0.61
▸ MMP2 P08253 10/20 0.45
▸ MMP13 P45452 9/20 0.45
▸ MMP1 P03956 5/20 0.45
▸ MMP14 P50281 5/20 0.45
▸ ADAMTS4 O75173 3/20 0.45
▸ ADAMTS5 Q9UNA0 2/20 0.45
▸ MEP1B Q16820 1/20 0.45
▸ MMP9 P14780 5/20 0.43
▸ MMP3 P08254 3/20 0.43
▸ MMP8 P22894 3/20 0.43
▸ MMP16 P51512 2/20 0.43
▸ ADAM17 P78536 1/20 0.43
▸ TARS1 P26639 1/20 0.40
▸ MMP7 P09237 1/20 0.40
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ PDK1 Q15118 1/20 0.40
▸ PDK2 Q15119 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7159422 0.80 CTSK (0.56) CTSKCTSSMMP2MMP13MMP1
SCHEMBL7163348 0.78 CTSK (0.49) CTSKCTSSMMP2MMP13MMP1
SCHEMBL7168737 0.78 CTSK (0.67) CTSKCTSSMMP2MMP13MMP1
SCHEMBL7163658 0.78 CTSK (0.64) CTSKCTSSMMP2MMP13MMP1
SCHEMBL8247244 0.76 CTSK (1.00) CTSKCTSSMMP2MMP13MMP1
SCHEMBL7160493 0.76 CTSK (0.62) CTSKCTSSMMP2MMP13MMP1
SCHEMBL7174464 0.75 CTSS (0.58) CTSKCTSSMMP2MMP13MMP1
SCHEMBL7165313 0.74 MMP13 (0.60) CTSKCTSSMMP2MMP13MMP1
SCHEMBL7248005 0.74 CTSK (0.59) CTSKCTSSMMP2MMP13MMP1
SCHEMBL5934588 0.73 CTSK (0.63) CTSKCTSSMMP13CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586466-B2 Enzyme inhibitor for use in the treatment of bone, oral, arthritic, paget's and hypercalcemic diseases SMITHKLINE BEECHAM CORPORATION 2003-07-01 — — US disclosed
Send feedback